Click for best price
Conjugate Vaccines Market Size, Share 2024
| Market size in 2023 |
US$ 9427.2 million
|
Forecast Market size by 2030 |
US$ 12360 million
|
| Growth Rate |
CAGR of 3.9% |
Number of Pages |
120 Pages |
This research report provides a comprehensive analysis of the Conjugate Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Conjugate Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Conjugate Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Conjugate Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Conjugate Vaccines market presents opportunities for various stakeholders, including Children, Adults. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Conjugate Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Conjugate Vaccines market was valued at US$ 9427.2 million in 2023 and is projected to reach US$ 12360 million by 2030, at a CAGR of 3.9% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Conjugate Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Conjugate Vaccines market.
Market Overview: The report provides a comprehensive overview of the Conjugate Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Conjugate Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Conjugate Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Conjugate Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Conjugate Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Conjugate Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Conjugate Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Conjugate Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Conjugate Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Conjugate Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
Market segment by Application
Children
Adults
Global Conjugate Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Conjugate Vaccines, market overview.
Chapter 2: Global Conjugate Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Conjugate Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Conjugate Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Conjugate Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Conjugate Vaccines Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 9427.2 million
|
| Forecast Market size by 2030 |
US$ 12360 million
|
| Growth Rate |
CAGR of 3.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
120 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Conjugate Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Conjugate Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Conjugate Vaccines Overall Market Size
2.1 Global Conjugate Vaccines Market Size: 2023 VS 2030
2.2 Global Conjugate Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Conjugate Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Conjugate Vaccines Players in Global Market
3.2 Top Global Conjugate Vaccines Companies Ranked by Revenue
3.3 Global Conjugate Vaccines Revenue by Companies
3.4 Global Conjugate Vaccines Sales by Companies
3.5 Global Conjugate Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Conjugate Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Conjugate Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjugate Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Conjugate Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Conjugate Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Conjugate Vaccines Market Size Markets, 2023 & 2030
4.1.2 Monovalent Conjugate Vaccines
4.1.3 Multivalent Conjugate Vaccines
4.2 By Type - Global Conjugate Vaccines Revenue & Forecasts
4.2.1 By Type - Global Conjugate Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Conjugate Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Conjugate Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Conjugate Vaccines Sales & Forecasts
4.3.1 By Type - Global Conjugate Vaccines Sales, 2019-2024
4.3.2 By Type - Global Conjugate Vaccines Sales, 2025-2030
4.3.3 By Type - Global Conjugate Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Conjugate Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Conjugate Vaccines Market Size, 2023 & 2030
5.1.2 Children
5.1.3 Adults
5.2 By Application - Global Conjugate Vaccines Revenue & Forecasts
5.2.1 By Application - Global Conjugate Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Conjugate Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Conjugate Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Conjugate Vaccines Sales & Forecasts
5.3.1 By Application - Global Conjugate Vaccines Sales, 2019-2024
5.3.2 By Application - Global Conjugate Vaccines Sales, 2025-2030
5.3.3 By Application - Global Conjugate Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Conjugate Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Conjugate Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Conjugate Vaccines Revenue & Forecasts
6.2.1 By Region - Global Conjugate Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Conjugate Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Conjugate Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Conjugate Vaccines Sales & Forecasts
6.3.1 By Region - Global Conjugate Vaccines Sales, 2019-2024
6.3.2 By Region - Global Conjugate Vaccines Sales, 2025-2030
6.3.3 By Region - Global Conjugate Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Conjugate Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Conjugate Vaccines Sales, 2019-2030
6.4.3 US Conjugate Vaccines Market Size, 2019-2030
6.4.4 Canada Conjugate Vaccines Market Size, 2019-2030
6.4.5 Mexico Conjugate Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Conjugate Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Conjugate Vaccines Sales, 2019-2030
6.5.3 Germany Conjugate Vaccines Market Size, 2019-2030
6.5.4 France Conjugate Vaccines Market Size, 2019-2030
6.5.5 U.K. Conjugate Vaccines Market Size, 2019-2030
6.5.6 Italy Conjugate Vaccines Market Size, 2019-2030
6.5.7 Russia Conjugate Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Conjugate Vaccines Market Size, 2019-2030
6.5.9 Benelux Conjugate Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Conjugate Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Conjugate Vaccines Sales, 2019-2030
6.6.3 China Conjugate Vaccines Market Size, 2019-2030
6.6.4 Japan Conjugate Vaccines Market Size, 2019-2030
6.6.5 South Korea Conjugate Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Conjugate Vaccines Market Size, 2019-2030
6.6.7 India Conjugate Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Conjugate Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Conjugate Vaccines Sales, 2019-2030
6.7.3 Brazil Conjugate Vaccines Market Size, 2019-2030
6.7.4 Argentina Conjugate Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Conjugate Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Conjugate Vaccines Sales, 2019-2030
6.8.3 Turkey Conjugate Vaccines Market Size, 2019-2030
6.8.4 Israel Conjugate Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Conjugate Vaccines Market Size, 2019-2030
6.8.6 UAE Conjugate Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Conjugate Vaccines Major Product Offerings
7.1.4 Novartis Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Neuron Biotech
7.2.1 Neuron Biotech Company Summary
7.2.2 Neuron Biotech Business Overview
7.2.3 Neuron Biotech Conjugate Vaccines Major Product Offerings
7.2.4 Neuron Biotech Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Neuron Biotech Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Conjugate Vaccines Major Product Offerings
7.3.4 Serum Institute of India Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Conjugate Vaccines Major Product Offerings
7.4.4 Pfizer Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Company Summary
7.5.2 Sanofi Pasteur Business Overview
7.5.3 Sanofi Pasteur Conjugate Vaccines Major Product Offerings
7.5.4 Sanofi Pasteur Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Pasteur Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Conjugate Vaccines Major Product Offerings
7.6.4 Bharat Biotech Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Biological
7.7.1 Biological Company Summary
7.7.2 Biological Business Overview
7.7.3 Biological Conjugate Vaccines Major Product Offerings
7.7.4 Biological Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Biological Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Conjugate Vaccines Major Product Offerings
7.8.4 GlaxoSmithKline Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Conjugate Vaccines Major Product Offerings
7.9.4 Merck Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Merck Key News & Latest Developments
7.10 CSL
7.10.1 CSL Company Summary
7.10.2 CSL Business Overview
7.10.3 CSL Conjugate Vaccines Major Product Offerings
7.10.4 CSL Conjugate Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 CSL Key News & Latest Developments
8 Global Conjugate Vaccines Production Capacity, Analysis
8.1 Global Conjugate Vaccines Production Capacity, 2019-2030
8.2 Conjugate Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Conjugate Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Conjugate Vaccines Supply Chain Analysis
10.1 Conjugate Vaccines Industry Value Chain
10.2 Conjugate Vaccines Upstream Market
10.3 Conjugate Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Conjugate Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Conjugate Vaccines in Global Market
Table 2. Top Conjugate Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Conjugate Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Conjugate Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Conjugate Vaccines Sales by Companies, (Units), 2019-2024
Table 6. Global Conjugate Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Conjugate Vaccines Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Conjugate Vaccines Product Type
Table 9. List of Global Tier 1 Conjugate Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Conjugate Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Conjugate Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Conjugate Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Conjugate Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Conjugate Vaccines Sales (Units), 2019-2024
Table 15. By Type - Global Conjugate Vaccines Sales (Units), 2025-2030
Table 16. By Application ? Global Conjugate Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Conjugate Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Conjugate Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Conjugate Vaccines Sales (Units), 2019-2024
Table 20. By Application - Global Conjugate Vaccines Sales (Units), 2025-2030
Table 21. By Region ? Global Conjugate Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Conjugate Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Conjugate Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Conjugate Vaccines Sales (Units), 2019-2024
Table 25. By Region - Global Conjugate Vaccines Sales (Units), 2025-2030
Table 26. By Country - North America Conjugate Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Conjugate Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Conjugate Vaccines Sales, (Units), 2019-2024
Table 29. By Country - North America Conjugate Vaccines Sales, (Units), 2025-2030
Table 30. By Country - Europe Conjugate Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Conjugate Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Conjugate Vaccines Sales, (Units), 2019-2024
Table 33. By Country - Europe Conjugate Vaccines Sales, (Units), 2025-2030
Table 34. By Region - Asia Conjugate Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Conjugate Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Conjugate Vaccines Sales, (Units), 2019-2024
Table 37. By Region - Asia Conjugate Vaccines Sales, (Units), 2025-2030
Table 38. By Country - South America Conjugate Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Conjugate Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Conjugate Vaccines Sales, (Units), 2019-2024
Table 41. By Country - South America Conjugate Vaccines Sales, (Units), 2025-2030
Table 42. By Country - Middle East & Africa Conjugate Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Conjugate Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Conjugate Vaccines Sales, (Units), 2019-2024
Table 45. By Country - Middle East & Africa Conjugate Vaccines Sales, (Units), 2025-2030
Table 46. Novartis Company Summary
Table 47. Novartis Conjugate Vaccines Product Offerings
Table 48. Novartis Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Novartis Key News & Latest Developments
Table 50. Neuron Biotech Company Summary
Table 51. Neuron Biotech Conjugate Vaccines Product Offerings
Table 52. Neuron Biotech Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Neuron Biotech Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India Conjugate Vaccines Product Offerings
Table 56. Serum Institute of India Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Conjugate Vaccines Product Offerings
Table 60. Pfizer Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sanofi Pasteur Company Summary
Table 63. Sanofi Pasteur Conjugate Vaccines Product Offerings
Table 64. Sanofi Pasteur Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Sanofi Pasteur Key News & Latest Developments
Table 66. Bharat Biotech Company Summary
Table 67. Bharat Biotech Conjugate Vaccines Product Offerings
Table 68. Bharat Biotech Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Bharat Biotech Key News & Latest Developments
Table 70. Biological Company Summary
Table 71. Biological Conjugate Vaccines Product Offerings
Table 72. Biological Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Biological Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline Conjugate Vaccines Product Offerings
Table 76. GlaxoSmithKline Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Merck Company Summary
Table 79. Merck Conjugate Vaccines Product Offerings
Table 80. Merck Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Merck Key News & Latest Developments
Table 82. CSL Company Summary
Table 83. CSL Conjugate Vaccines Product Offerings
Table 84. CSL Conjugate Vaccines Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. CSL Key News & Latest Developments
Table 86. Conjugate Vaccines Production Capacity (Units) of Key Manufacturers in Global Market, 2022-2024 (Units)
Table 87. Global Conjugate Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Conjugate Vaccines Production by Region, 2019-2024 (Units)
Table 89. Global Conjugate Vaccines Production by Region, 2025-2030 (Units)
Table 90. Conjugate Vaccines Market Opportunities & Trends in Global Market
Table 91. Conjugate Vaccines Market Drivers in Global Market
Table 92. Conjugate Vaccines Market Restraints in Global Market
Table 93. Conjugate Vaccines Raw Materials
Table 94. Conjugate Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Conjugate Vaccines Downstream
Table 96. Conjugate Vaccines Downstream Clients in Global Market
Table 97. Conjugate Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Conjugate Vaccines Segment by Type in 2023
Figure 2. Conjugate Vaccines Segment by Application in 2023
Figure 3. Global Conjugate Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Conjugate Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Conjugate Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Conjugate Vaccines Sales in Global Market: 2019-2030 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Conjugate Vaccines Revenue in 2023
Figure 9. By Type - Global Conjugate Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Conjugate Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Conjugate Vaccines Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Conjugate Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Conjugate Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Conjugate Vaccines Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Conjugate Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Conjugate Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Conjugate Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Conjugate Vaccines Sales Market Share, 2019-2030
Figure 23. US Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Conjugate Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Conjugate Vaccines Sales Market Share, 2019-2030
Figure 37. China Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Conjugate Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Conjugate Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Conjugate Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Conjugate Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Conjugate Vaccines Production Capacity (Units), 2019-2030
Figure 53. The Percentage of Production Conjugate Vaccines by Region, 2023 VS 2030
Figure 54. Conjugate Vaccines Industry Value Chain
Figure 55. Marketing Channels
